Market closed
Biofrontera Inc./$BFRI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Ticker
$BFRI
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
93
ISIN
US09077D2099
Website
Biofrontera Inc. Metrics
BasicAdvanced
$6.5M
-
-$3.22
0.38
-
Price and volume
Market cap
$6.5M
Beta
0.38
52-week high
$1.10
52-week low
$0.65
Average daily volume
74K
Financial strength
Current ratio
1.722
Quick ratio
0.934
Long term debt to equity
98.669
Total debt to equity
111.031
Interest coverage (TTM)
-8.17%
Management effectiveness
Return on assets (TTM)
-43.00%
Return on equity (TTM)
-384.98%
Valuation
Price to revenue (TTM)
0.108
Price to book
1.46
Price to tangible book (TTM)
1.47
Price to free cash flow (TTM)
-0.388
Growth
Revenue change (TTM)
9.54%
Earnings per share change (TTM)
-75.27%
3-year revenue growth (CAGR)
15.69%
3-year earnings per share growth (CAGR)
-66.50%
Biofrontera Inc. News
AllArticlesVideos
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025
Accesswire·3 days ago
Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis
GlobeNewsWire·1 week ago
Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biofrontera Inc. stock?
Biofrontera Inc. (BFRI) has a market cap of $6.5M as of May 09, 2025.
What is the P/E ratio for Biofrontera Inc. stock?
The price to earnings (P/E) ratio for Biofrontera Inc. (BFRI) stock is 0 as of May 09, 2025.
Does Biofrontera Inc. stock pay dividends?
No, Biofrontera Inc. (BFRI) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Biofrontera Inc. dividend payment date?
Biofrontera Inc. (BFRI) stock does not pay dividends to its shareholders.
What is the beta indicator for Biofrontera Inc.?
Biofrontera Inc. (BFRI) has a beta rating of 0.38. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.